CAPTRUST Financial Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28,051
| Closed | -$3.53M | – | 2173 |
|
|
2023
Q4 | $3.53M | Buy |
28,051
+4,022
| +17% | +$507K | 0.01% | 681 |
|
|
2023
Q3 | $2.25M | Buy |
24,029
+11,708
| +95% | +$1.1M | 0.01% | 819 |
|
|
2023
Q2 | $1.1M | Sell |
12,321
-4
| -0% | -$357 | ﹤0.01% | 1146 |
|
|
2023
Q1 | $1.32M | Hold |
12,325
| – | – | 0.01% | 899 |
|
|
2022
Q4 | $1.51M | Buy |
+12,325
| New | +$1.51M | 0.01% | 807 |
|
|
2022
Q3 | – | Sell |
-1,594
| Closed | -$148K | – | 2197 |
|
|
2022
Q2 | $148K | Buy |
1,594
+548
| +52% | +$50.9K | ﹤0.01% | 1909 |
|
|
2022
Q1 | $123K | Buy |
1,046
+1,013
| +3,070% | +$119K | ﹤0.01% | 2109 |
|
|
2021
Q4 | $4K | Hold |
33
| – | – | ﹤0.01% | 4156 |
|
|
2021
Q3 | $5K | Hold |
33
| – | – | ﹤0.01% | 3931 |
|
|
2021
Q2 | $4K | Hold |
33
| – | – | ﹤0.01% | 3930 |
|
|
2021
Q1 | $4K | Hold |
33
| – | – | ﹤0.01% | 3792 |
|
|
2020
Q4 | $6K | Hold |
33
| – | – | ﹤0.01% | 2753 |
|
|
2020
Q3 | $5K | Buy |
33
+30
| +1,000% | +$4.55K | ﹤0.01% | 2511 |
|
|
2020
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2844 |
|